RecruitingNot ApplicableNCT07339904

ProLARS Trial: Prospective Longitudinal Follow-up of Low Anterior Resection Syndrome (LARS) and COREFO Score After Rectum Surgery in Patients Undergoing Upfront Surgery or Different Neo-adjuvant Treatment Regimens


Sponsor

University Hospital, Antwerp

Enrollment

100 participants

Start Date

Aug 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

OBJECTIVE Low anterior resection syndrome (LARS) is a term for functional bowel complaints occurring after low anterior resection. Symptoms can range from faecal incontinence and frequent loose stools to urgency and incomplete emptying with great impact on quality of life. Little is known about the longitudinal evolution of LARS and the impact of different schedules of neoadjuvant chemoradiotherapy combined with surgery. The investigators aim to investigate the incidence and evolution of functional bowel complaints in function of different neoadjuvant treatment regimens, type of surgery and adjuvant therapy in patients who undergo surgery for rectal cancer. The investigators focus on following objectives: evolution of LARS- and COREFO-scores per treatment regimen and their impact on work incapacity; identification of possible risk factors potentially related to functional outcome; monitoring and treatment of LARS. METHODS This will be a multicentre prospective interventional study. The study population will consist of adult patients with rectal cancer, regardless of any neo-adjuvant therapy. Patients will be included for 5 years with a 2 year postoperative follow-up. Interim analysis will be made after 2 years of inclusion. Patients with intellectual disability or clinical colon obstruction are excluded. Automated online questionnaires including LARS and COREFO scores, incapacity for work and defecation quality will be sent at different time points (figure 1) using REDCap. RESULTS and CONCLUSIONS Longitudinal change of LARS- and COREFO-scores will be visually summarized. Patient, disease or procedure specific risk factors will be assessed as well. LARS is proven to be the principal postoperative problem after rectal surgery. If the investigators can predict the severity of LARS (minor or major LARS), this can be extremely helpful in deciding whether to perform a sphincter-sparing resection or a rectal amputation instead. Furthermore, the investigators want to offer perspective to patients who are susceptible to a disturbed postoperative bowel function.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a prospective study following patients with rectal cancer who undergo bowel-sparing surgery (where the rectum is reconnected rather than removed permanently) to track bowel function problems over time. These problems — collectively known as low anterior resection syndrome (LARS) — can significantly affect quality of life after rectal cancer surgery. **You may be eligible if...** - You are 18 or older - You have been diagnosed with rectal cancer and are planned for bowel-sparing surgery (total or partial mesorectal excision), with or without pre-surgery treatments like radiation or chemotherapy **You may NOT be eligible if...** - You have inflammatory bowel disease (Crohn's disease or ulcerative colitis) - You have dementia or an intellectual disability - You needed an emergency bowel procedure (like a stent or diverting stoma) before planned surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionnaire

Online questionnaire regarding LARS- and COREFO-scores, quality of defecation process, incapacity for work and initiation of treatment for potential LARS at different moments in time


Locations(1)

University Hospital Antwerp

Edegem, Antwerp, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07339904


Related Trials